Investor Relations

A legacy of execution excellence, strategic corporate stewardship, and shareholder value creation

Corporate overview

AmerisourceBergen is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain

Latest quarterly results

Financial highlights

FY20 Revenue

  • Pharmaceutical Distribution: $182,467M1
  • Global Commercialization Services & Animal Health2: $7,525M
  • 1. Includes $98M of intersegment eliminations and primarily represents the elimination of certain Pharmaceutical Distribution Services reportable segment sales to MWI.
  • 2. Reported as Other

FY20 Adjusted operating income

  • Pharmaceutical Distribution: $1,807M
  • Global Commercialization Services & Animal Health: $400M
  • 3. Note: FY20 GAAP Operating loss of $(5,135). For more information and a reconciliation of non-GAAP financial measures, refer to the Company’s Current Report on Form 8-K furnished under item 2.02 on November 5, 2020

AmerisourceBergen: By the numbers


Annual revenues


Team Members


Global offices

Summary Annual Report

Recent news

See all news

Events and presentations

Events and presentations

See all events